DBV Technologies SA (DBVT)
9.80
-0.14
(-1.41%)
USD |
NASDAQ |
Nov 05, 16:00
9.79
-0.01
(-0.10%)
After-Hours: 20:00
DBV Technologies SG&A Expense (TTM) : 67.50M for Sept. 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 67.50M |
| June 30, 2026 | 56.62M |
| March 31, 2026 | 45.54M |
| December 31, 2025 | 36.08M |
| September 30, 2025 | 28.71M |
| June 30, 2025 | 28.05M |
| March 31, 2025 | 28.69M |
| December 31, 2024 | 31.36M |
| September 30, 2024 | 33.95M |
| June 30, 2024 | 33.06M |
| March 31, 2024 | 33.18M |
| December 31, 2023 | 31.94M |
| September 30, 2023 | 31.02M |
| Date | Value |
|---|---|
| June 30, 2023 | 29.17M |
| March 31, 2023 | 26.16M |
| December 31, 2022 | 25.93M |
| September 30, 2022 | 24.49M |
| June 30, 2022 | 28.86M |
| March 31, 2022 | 31.59M |
| December 31, 2021 | 34.91M |
| September 30, 2021 | 29.25M |
| June 30, 2021 | 19.88M |
| March 31, 2021 | 10.41M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Cellectis SA | 21.32M |
| Akari Therapeutics Plc | 8.796M |
| Bicycle Therapeutics Plc | 66.46M |
| EDAP TMS SA | 26.00M |
| Autolus Therapeutics Plc | 152.92M |